Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 23, 2026 09:25 ET | Source: Asimov

Asimov Launches Chrysalis Transposase, a Wholly-Owned Genome Integration Tool for Biotherapeutics Production

Engineered from the genomes of multiple butterfly species, Chrysalis transposase achieves high titers, stable expression, and faster cell recovery.
June 18, 2026 07:00 ET | Source: Asimov

Asimov Announces Strategic Partnership with the Rosalind & Morris Goodman Cancer Institute at McGill University to Advance Next-Generation Biologics

Asimov will provide technologies for cell line development and process development to researchers at the Goodman Cancer Institute.
May 07, 2026 07:00 ET | Source: Asimov

Asimov Completes Lead Optimization Campaign with Mabylon AG to Advance Trispecific Antibody for Tree Pollen Allergies

Mabylon AG leveraged Asimov's lead optimization offering, Rapid Pools, to de-risk candidate selection before advancing into cell line development.
March 19, 2026 07:00 ET | Source: Asimov

Asimov Launches RNA Edge, a Lab-in-the-Loop Platform for AI Optimization of RNA Therapeutic Candidates

RNA Edge combines AI sequence optimization, novel genetic parts, and validation in application-relevant cell models to improve expression and half-life.
March 17, 2026 07:00 ET | Source: Asimov

Asimov Announces Cell Line Development Partnership with Score Pharma to Advance Biosuperior Antibody Therapeutics

Asimov partners with Score Pharma to develop biosuperior antibody therapeutics with enhanced ADCC activity using Asimov's CHO Edge platform.